Amarantus Bioscience Holdings Inc (AMBS)

[barcode27]

Another addition to AMBS management team:

http://www.amarantus.com/about/management-team

Paul Jorgensen
Head of Diagnostics Product Development

Mr. Jorgensen is a biotechnology executive with over twenty years' experience in the areas of *in-vitro* diagnostics development, validation and manufacturing. He has worked at a number of large biotech and diagnostics firms including Boehringer-Mannheim, Chiron Corporation and the diagnostics division of Bio-Rad Laboratories. In 2000 he helped found and served as Director, Operations for AcroMetrix Corporation which manufactured products for molecular diagnostics and was a pioneer in standardizing viral load assays. The company was sold to Life Technologies in 2009. Most recently Mr. Jorgensen was Director of Development and Laboratory Operations for Tethys Bioscience where he established Tethys' CLIA clinical lab and was responsible for the launch of the company's PreDx Diabetes Risk Score product. Mr. Jorgensen has a degree in Biochemistry and Biophysics from the University of California at Davis.